ClearBridge Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

ClearBridge Investments’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-105,780	Closed	-$33.5M	–	783
2023 Q4	$33.5M	Buy	105,780 +11,390	+12%	+$2.21M	0.03%	394
2023 Q3	$16M	Hold	94,390	–	–	0.02%	456
2023 Q2	$20.5M	Buy	94,390 +93,023	+6,805%	+$19.9M	0.02%	438
2023 Q1	$248K	Buy	+1,367	New	+$261K	﹤0.01%	696

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

ClearBridge Investments's KRTX Position: Q1 2024 in Review

ClearBridge Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 105,780 shares — an estimated $33.5M sold.

ClearBridge Investments first reported a position in KRTX in Q1 2023 and held it in 4 quarters. The position peaked at $33.5M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

ClearBridge Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ClearBridge Investments sold 105,780 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $33.5M.
ClearBridge Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
ClearBridge Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $33.5M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on ClearBridge Investments's 13F filing for Q1 2024, filed 13 May 2024.